A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis

Rosella Mechelli (Lead / Corresponding author), Renato Umeton, Gianmarco Bellucci, Rachele Bigi, Virginia Rinaldi, Daniela F. Angelini, Gisella Guerrera, Francesca C. Pignalosa, Sara Ilari, Marco Patrone, Sundararajan Srinivasan, Gabriel Cerono, Silvia Romano, Maria C. Buscarinu, Serena Martire, Simona Malucchi, Doriana Landi, Lorena Lorefice, Raffaella Pizzolato Umeton, Eleni AnastasiadouPankaj Trivedi, Arianna Fornasiero, Michela Ferraldeschi, IMSGC WTCCC2, Alessia Di Sapio, Gerolama Marfia, Eleonora Cocco, Diego Centonze, Antonio Uccelli, Dario Di Silvestre, Pierluigi Mauri, Paola de Candia, Sandra D’Alfonso, Luca Battistini, Cinthia Farina, Roberta Magliozzi, Richard Reynolds, Sergio E. Baranzini, Giuseppe Matarese, Marco Salvetti (Lead / Corresponding author), Giovanni Ristori

Research output: Contribution to journalArticlepeer-review

3 Downloads (Pure)

Abstract

Recent sero-epidemiological studies have strengthened the hypothesis that Epstein–Barr virus (EBV) may be a causal factor in multiple sclerosis (MS). Given the complexity of the EBV–host interaction, various mechanisms may be responsible for the disease pathogenesis. Furthermore, it remains unclear whether this is a disease-specific process. Here, we showed that genes encoding EBV interactors are enriched in loci associated with MS but not with other diseases and in prioritized therapeutic targets. Analyses of MS blood and brain transcriptomes confirmed a dysregulation of MS-associated EBV interactors affecting the CD40 pathway. Such interactors were strongly enriched in binding sites for the EBV nuclear antigen 2 (EBNA2) viral transcriptional regulator, often in colocalization with CCCTC binding factor (CTCF) and RNA Polymerase II Subunit A (POLR2A). EBNA2 was expressed in the MS brain. The 1.2 EBNA2 allele downregulated the expression of the CD40 MS-associated gene analogously to the CD40 MS-risk variant. Finally, we showed that the 1.2 EBNA2 allele associates with the risk of MS. This study delineates how host and viral genetic variability converge in MS-specific pathogenetic mechanisms.

Original languageEnglish
Article numbere2418783122
Number of pages11
JournalProceedings of the National Academy of Sciences of the United States of America
Volume122
Issue number14
Early online date4 Apr 2025
DOIs
Publication statusPublished - 8 Apr 2025

Keywords

  • autoimmunity
  • Epstein–Barr virus
  • multiple sclerosis

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis'. Together they form a unique fingerprint.

Cite this